Cream combo tested for scalp bumps in men of african descent

NCT ID NCT05608499

First seen Jun 27, 2026 ยท Last updated Jun 27, 2026

Summary

This study tested Duobrii, a prescription cream that combines a strong steroid with a retinoid, for treating early-mild acne keloidalis nuchae (AKN) โ€” a chronic scalp condition causing bumps and scarring, mainly in men of African descent. The trial planned to enroll 15 adults with mild AKN and track changes in lesion counts over 12 weeks. However, the study was terminated early, so results are limited.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACNE KELOIDALIS NUCHAE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Icahn School of Medicine at Mount Sinai

    New York, New York, 10029, United States